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Background: Vascular graft infections (VGI) are difficult to diagnose and treat, and
despite redo surgery combined with antimicrobial treatment, outcomes are often
poor. VGI diagnosis is based on a combination of clinical, radiological, laboratory
and microbiological criteria. However, as many of the VGI patients are already under
antimicrobial treatment at the time of redo surgery, microbiological identification is
often difficult and bacterial cultures often remain negative rendering targeted treatment
impossible. We aimed to assess the benefit of 16S rRNA gene polymerase chain reaction
(broad-range PCR) for better microbiological identification in patients with VGI.
Methods: We prospectively analyzed the clinical, microbiological, and treatment data of
patients enrolled in the observational Vascular Graft Cohort Study (VASGRA), University
Hospital Zurich, Switzerland. The routine diagnostic work-up involved microbiological
cultures of minced tissue samples, and the use of molecular techniques in parallel.
Patient-related and microbiological data were assessed in descriptive analyses, and we
calculated sensitivity, specificity, negative and positive predictive value for broad-range
16S rRNA gene PCR versus culture (considered as gold standard).
Results: We investigated 60 patients (median age 66 years (Interquartile range [IQR]
59–75)) with confirmed VGI between May 2013 and July 2017. The prevalence of
antimicrobial pretreatment at the time of sampling was high [91%; median days of
antibiotics 7 days (IQR 1–18)]. We investigated 226 microbiological specimens. Thereof,
176 (78%) were culture-negative and 50 (22%) were culture-positive. There was a
concordance of 70% (158/226) between conventional culture and broad-range PCR
(sensitivity 58% (95% CI 43–72); specificity 74% (67–80%)). Among the group of 176
culture-negative specimens, 46 specimens were broad-range PCR-positive resulting in
identification of overall 69 species. Among the culture and/or broad-range PCR-positive
specimens (n = 96), 74 (77%) were monomicrobial and 22 (23%) polymicrobial, whereas
the rate of polymicrobial samples was higher in broad-range PCR-positive specimens
(93%).
Ajdler-Schaeffler et al. PCR in Vascular Graft Infection
Conclusions: Combined cultures and broad-range 16S rRNA gene PCR from
periprosthetic tissue and/or explanted vascular grafts increased the diagnostic accuracy
in VGI, particularly in patients already under antimicrobial treatment at the time of redo
surgery. Ideally, antimicrobial treatment should be withheld until surgical sampling in order
to optimize microbiological diagnostics.
Clinical trials.gov identifier: NCT01821664
Keywords: 16S rRNA gene polymerase chain reaction, vascular graft infection, pathogen identification,
microbiological diagnosis, tissue culture
INTRODUCTION
Vascular graft infections (VGIs) are among the most serious
complications in vascular surgery (1), increasing the risk
of morbidity and mortality in affected patients substantially.
Extracavitary groin or limb graft infections occur in about 2–
6%, whereas intracavitary abdominal or thoracic graft infections
are less common (0.5–2%). Vascular surgical site infections
are combining the clinical features of biofilm-mediated and
chronic wound infections due to both, the implantation of
foreign material and circulatory disturbances. Therefore, therapy
strategies solely relying on antimicrobial treatment oftentimes
fail, and redo-surgery is needed. Traditional surgical salvage
procedures include complete or partial graft removal with in-
situ or extra-anatomical reconstruction and local treatment with
muscle flap, omentum, or negative pressure wound therapy
(NWPT) (1, 2).
The broadly used definition of VGI is based on clinical,
radiological, and laboratory criteria (3–5). Even though
histopathologic work-up is routinely recommended, no
standardized cut-off levels for polymorphonuclear neutrophil
counts per high power field have been defined. Microbiological
evidence of pathogens remains the cornerstone of diagnosis,
and the detection of microorganisms in blood cultures and/or
the extraction of bacteria from the periprosthetic tissue
biofilm by tissue homogenization are essential for diagnosis.
However, blood cultures have a low sensitivity in detecting
pathogens causing a VGI, since biofilm formation on the implant
material oftentimes precludes planctonic seeding of bacteria
and therefore their detection in blood (4). Cultures from the
prosthetic sonicate fluid have only rarely been validated for
VGIs (6), especially due to the lack of standardization caused
by high rates of polymicrobial infections and different involved
anatomical regions and graft materials. Broad-range 16S rRNA
gene polymerase chain reaction (broad-range PCR) has not
been established in the routine diagnostic work-up of VGIs
yet. These molecular genetic techniques (7) are providing
sensitive methods for more accurate pathogen identification,
especially in case of infections with antimicrobial pretreatment
and fastidious to grow or non-cultivable pathogens like Coxiella
burnetii, Tropheryma whipplei, and Mycobacteria (8–10).
The method bears the risk of sample contamination and is
allegedly less effective in case of polymicrobial infections. It is
estimated that up to one third of all VGI are polymicrobial,
which is potentially affecting the sensitivity of broad-range PCR
and therefore its effectiveness in the reliable identification of
causative pathogens. We aimed to assess whether broad-range
PCR in addition to conventional microbiological cultures
would improve diagnostics of VGIs of patients included in
the prospective, observational Vascular Graft Cohort Study
(VASGRA).
MATERIALS AND METHODS
Study Design and Study Population
All participants of VASGRAwith provenVGIs betweenMay 2013
and July 2017 were eligible for this analysis. In the VASGRA
cohort clinical, laboratory and microbiological information is
collected at three-monthly follow-up visits. The prospective,
observational cohort is located at the University hospital of
Zurich (Switzerland), a 880-bed tertiary-care referral center. We
obtained written informed consent from all participants. The
Independent Ethics Committee of Zurich approved the study
(KEK_2012-0583).
Definitions and Classifications
We used the Management of Aortic Graft Infection
Collaboration (MAGIC) criteria (5) for the diagnosis of
VGI. A multidisciplinary team of infectious disease specialists,
microbiologists, cardiovascular surgeons and radiologists
adjudicated each criterion. In addition, each VGI was
additionally classified according to the Samson classification
(11). Extracavitary VGIs mainly included the groin and/or the
lower extremities, whereas intracavitary VGIs involved the
abdomen or less commonly the thorax (1).
Microbiological Analyses
Clinical specimens from suspected VGIs were sent to the Institute
for Medical Microbiology, Zurich, Switzerland for conventional
microbiological culture as well as bacterial broad-range PCR.
For strict pathogens, we considered the microbiologic criterion
as fulfilled when there was one positive culture and/or a
positive broad-range PCR from an intraoperative specimen.
For potential “contaminant” pathogens (e.g., coagulase-negative
Staphylococci, Corynebacterium spp., Propionibacterium acnes),
at least two positive intraoperative specimens were required.
Microscopy
We performed Gram stains of clinical specimens according to
standard procedures. Ten 1,000-fold visual fields were used to
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determine the mean bacterial count (no bacteria; detection of
bacteria after enrichment; detection of some scattered bacteria;
detection of bacteria); and ten 100-fold visual fields were used to
determine the mean count for leucocytes (no leucocytes, some
scattered amounts of leucocytes, few leucocytes, leucocytes in
lumps).
Cultures
Tissue specimens were placed in sterile 0.9% sodium chloride
solution in the operating theater and immediately transferred
to the laboratory. Upon receipt, the specimens were minced
using an IKA Ultra-Turrax tissue homogenizer (Sigma-Aldrich,
Buchs, Switzerland) and culture media were inoculated and
incubated under aerobic and anaerobic conditions. Sheep agar
plates without antibiotics (COS; bioMérieux, Marcy l’Etoile,
France), and with colistin-nalidixic acid (CNA) were used for
the detection of Gram-positive bacteria (bioMérieux), while
MacConkey (MCK) agar plates (bioMérieux) were used for
Gram-negative bacteria and Sabouraud agar plates for fungi. In
addition, thioglycolate broth, aerobic selective chocolate agar
plates (HAE2; bioMérieux), anaerobic sheep blood agar plates
with hemin and vitamin K1 (Brucella agar; BD), laked sheep
blood Brucella agar plates with kanamycin and vancomycin (BD),
and phenylethylalcohol agar plates with vitamin K1 (BD) were
used. Growth on agar plates was examined at 24, 48, and 72 h as
well as after one week; the thioglycolate broth was examined up to
day 10 and the Sabouraud agar plates up to day 20 (12). Antibiotic
susceptibility testing was performed according to EUCAST
recommendations (13).
Bacterial and Fungal Identification
16S broad-range PCR was performed as a conventional, semi
nested PCR using three amplification primers as described
before (14, 15). PCR amplification was assessed optically on
silver-stained polyacrylamide gel and compared to the buffer
background as described by Rampini et al. (15). Reagents and
buffers were routinely controlled to be low bacterial DNA-
containing prior to use. Broad-range fungal inter spacer region
(ITS) polymerase chain reaction (PCR) for the detection and
identification of fungi in clinical specimens was performed as
described before (16).
We used matrix-assisted laser desorption ionization–
time of flight (MALDI-TOF) and 16S rRNA gene or ITS
sequencing for identification (7, 14, 16–18). 16S rRNA sequence
homology analyses were done using GenBank (NCBI) and the
SmartGene IDNS database and software (SmartGene GmbH,
Zug, Switzerland).
Statistical Analysis
To analyze the patient characteristics and the characteristics of
the VGI, we used all available diagnostic samples (performed in
internal or external laboratories). For the further analysis, we
restricted the analysis to patients where i.a. deep or superficial
wound tissue specimens, NPWT foams or explanted vascular
grafts were investigated in parallel with broad-range PCR and
conventional microbiological cultures. Samples with only broad-
range PCR or microbiological cultures were excluded. We
present results as medians with interquartile range (IQR), crude
numbers, percentages and 95% confidence intervals (CI) of
specimens/species. We compared sensitivity, specificity, positive
predictive value and negative predictive value of 16S rRNA
gene broad-range PCR and conventional culture (considered
as gold standard) (19). We performed statistical analyses with
Stata (version 15.1/SE; Stata Corporation, College Station, Texas,
USA).
RESULTS
Patient Characteristics
The VASGRA dataset included information on 508 participants.
We excluded 387 control patients because they underwent
routine vascular surgery without infection. Of the remaining 121
patients with suspected VGI, 61 patients were excluded due to
unconfirmed VGIs (n = 30) or due to missing parallel sampling
of intraoperative tissue (n = 31) (Figure 1). Considering also
patients with positive blood cultures (n= 17) we finally included
60 prospective patients with proven VGIs (82% men) in the
analysis (Table 1). The median age, body mass index (BMI) and
Charlson Comorbidity Index of participants were 66 years (IQR
58.5–75), 28 kg/m2 (25–30), and 2 (1–3), respectively. VGIs
occurred after a median of 3 months (IQR 1–22) after the index
surgery.
Microbiological Specimens
Wefinally investigated 226 intraoperative tissue samples in which
both, tissue cultures and broad-range PCR were performed
in parallel (Table 1, Figure 2). The tissue samples originated
from extracavitary (22%), intracavitary abdominal (55%), or
thoracic (20%) VGIs. The remaining tissue samples (3%) were
isolated from secondary VGIs due to endovascular treatment of
mycotic aneurysms. Microbiological samples were obtained after
a median of 25 days (9-91) after diagnosis of VGI. At the time
of sampling, 91% of patients were under antimicrobial treatment
for a median of 7.5 days (IQR 1–18.5).
FIGURE 1 | Patient selection. For this figure all microbiological samples were
included (also when only broad range PCR or culture had been performed).
VGI, Vascular graft infection; PCR, polymerase chain reaction.
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TABLE 1 | Characteristics of patients and samples.
Patient
characteristics
n = 60
Male n (%) 49 (100)
Age in years at infection, median (IQR) 66 (58–75)
Body mass index (kg/m2), median (IQR) 28 (25–30)
Charlson Comorbidity Index, median (IQR) 2 (1–3)
Months since index surgery, median (IQR) 3 (1–22)
Days since graft infection, median (IQR) 6 (0–22)
Localization of vascular graft
Abdominal intracavitary, n (%) 33 (55)
Thoracic intracavitary, n (%) 11 (20)
Extracavitary, n (%) 13 (22)
Other, n (%) 3 (3)
Samson Classification
3, n (%) 29 (49)
4, n (%) 15 (25)
5, n (%) 16 (26)
Specimens, n (%) 226 (100)
Number of specimens per patient, median (IQR) 3 (1–4)
Material, n (%)
Deep wound, n (%) 156 (69)
Superficial wound, n (%) 30 (13)
Vascular graft, n (%) 6 (3)
Other (e.g., biopsy, blood culture), n (%) 20 (9)
NPWT foam, n (%) 14 (6)
Antibiotic treatment at sampling, n (%)
Yes 206 (91)
Culture-positive on antimicrobial treatment, n (%) 40/206 (19)
PCR-positive on antimicrobial treatment, n (%) 71/206 (34)
Days on continuous antimicrobial treatment, Median (IQR) 7 (1–18)
IQR, Interquartile range; NWPT, Negative pressure wound therapy.
Performance of Broad-Range PCR as
Compared to Intraoperative Tissue
Cultures
Among the 226 intraoperative specimens, 176 (78%)
were culture-negative and 50 (22%) were culture-positive
(Figures 2, 3). Among the 176 culture-negative samples, 46
were broad-range PCR-positive (≥2 organisms 20%). Among
the 50 culture-positive samples (≥2 organisms 26%), 21 were
broad-range PCR-negative and 29 broad-range PCR-positive
(≥2 organisms 38%). Among the latter, 29 specimens, 11/29
(38%) yielded a non-identical species. Taken together, there was a
concordance of 70% (159/226) between conventional culture and
broad-range PCR. Compared to microbiological cultures as the
gold standard, broad-range PCR had a sensitivity of 58% (95% CI
43–72), a specificity of 74% (67–80), a positive predictive value
(PPV) of 39% (28–51), and a negative predictive value (NPV)
of 86% (80–91). Combining culture and molecular diagnostics,
the number of positive microbiological results almost doubled
rising from 50/226 (22%) to 96/226 (42%). We did a sub-analysis
were we ignored the presence of Candida sp, because panfungal
PCR was not done for all samples. The diagnostic accuracy did
not change markedly [sensitivity: 58% (39–75), specificity 76%
(70–82), PPV 29% (19–42), NPV 91% (86–95)].
Among the culture and/or broad-range PCR-positive
specimens (n = 96), 74 (77%) were monomicrobial and 22
(23%) polymicrobial. We detected in 14% two species per
sample, and >3 species in 9%. The polymicrobial specimens
were culture- and broad-range PCR-positive-positive in 11 cases,
culture-positive and broad-range PCR-negative in two cases
and culture-negative, broad-range PCR-positive-positive in nine
cases.
Detection of Intraoperative Species by
Broad-Range PCR as Compared to
Conventional Cultures
The detected species in the culture and/or broad-range PCR-
positive specimens were not always identical. Details on the
diagnostics of the detected species are presented in Table 2 and
Supplementary Table 1. Of all bacterial species, Gram-positive
bacteria clearly predominated (44%) compared to Gram-negative
bacteria (28%), fungi (6%), anaerobes (8%), and miscellaneous
other bacteria (14%). Among all detected species, 22 (17%) were
culture- and broad-range PCR-positive, 40 (30%) were culture-
positive/ broad-range PCR-negative and 69 (53%) were culture-
negative/broad-range PCR-positive.
Culture- and broad-range PCR-positive species: Among the 22
species with positive results in both methods, Candida sp. (45%)
and S. epidermidis (23%) predominated. At the time of sampling,
21/22 patients were on antimicrobial treatment for a median of 6
days (IQR 3–6).
Culture-positive/broad-range PCR-negative species: The 40
species with only positive cultures, mainly included Candida sp.
(20%), S. epidermidis (13%) and Enterococcus spp. (15%). As the
bacterial load was relatively low, no bacteria were detected (or
only bacteria after enrichment) in 85% (Figure 4A). Leucocytes
were detected in some scattered amounts, in a few amounts or in
lumps in 35, 12.5, and 12.5%, respectively (Figure 4B).
Culture-negative/broad-range PCR-positive species: Among
the 69 broad-range PCR-positive/ culture-negative species,
S. epidermidis and Streptococcus spp. were detected in 33%,
whereas Gram-negative bacteria, anaerobes and mycobacteria
were detected in 38, 4, and 7% of the remaining isolates,
respectively. No bacteria per visual field were detected in
88% of these instances (Figure 4A), and no or only scattered
amounts of leucocyte count were detected by visual field in 62%
(Figure 4B).
DISCUSSION
Combining culture-based and molecular diagnostics increased
the microbiological yield in a substantial proportion of patients
with VGIs. Our study is the first prospective cohort study to
explore the diagnostic performance of broad-range PCR for a
large number of patients. Our study showed that intraoperative
tissue-/explanted vascular graft sequencing combined with
culture showed more sensitivity to identify the causative
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FIGURE 2 | Overview of microbiological results. Here we considered only microbiological samples of patients when culture and PCR were performed in parallel. VGI,
vascular graft infection; PCR, polymerase chain reaction, polymicrobial ≥2 species in one sample.
FIGURE 3 | Accuracy of broad-range PCR compared to conventional culture
in 226 intraoperative clinical specimens from 60 patients with confirmed
vascular graft infections. PCR, polymerase chain reaction.
pathogen as compared to intraoperative tissue cultures alone.
As many of the patients were under antimicrobial treatment at
the time of sampling, the rate of culture-negative tissue samples
was as high as 78%. In addition, potential contaminant bacterial
pathogens were taken into account. The specificity (74%) of
broad-range PCR was better than its sensitivity (58%).
To date, microbiological results of pre- or intraoperatively
obtained cultures from different tissue samples have only rarely
been assessed in VGIs (20–22). We previously analyzed the
diagnostic value of bacteria cultured from NPWT-foams as
compared to bacteria obtained from deep tissue perivascular
samples and found that sensitivity (58%) as well as specificity
(86%) from NPWT-foams were poor (20). Another study
assessed the diagnostic accuracy of blood cultures in identifying
the causative pathogen among 17 patients with VGIs (22).
Bisharat et al. found that microorganisms in blood cultures do
not necessarily indicate a causal relationship as only 17.6% of
these patients had the same microorganisms in blood cultures,
excised vascular grafts, or perigraft tissue cultures, respectively.
The use of molecular techniques for the diagnosis of VGI
has been suggested in the past (3, 23). However, only one
retrospective study has assessed the diagnostic accuracy of
broad-range PCR and sonicate-fluid cultures as compared to
perivascular deep tissue and/or blood cultures among 22 patients
(24 cases) with VGIs (6). The study found high rates of sonicate-
fluid cultures- (79%) and broad-range 16S rRNA PCR-positivity
(67%). However, blood cultures, intraoperative tissue specimens
and parallel PCR/deep tissue cultures were not taken routinely,
therefore preventing adequate statistical analyses and exclusion
of potential contaminant pathogens. In detailed analyses,
we found that broad-range PCR results contributed to the
diagnosis of VGI in 21/34 (62%) patients with culture-negative
infections.
Comparing perivascular tissue cultures (current gold
standard) and broad-range PCR, we observed a lack of sensitivity
of the molecular diagnosis. Indeed, broad-range PCR was not
confirmatory in molecular species identification in 40 out
of 61 instances with a positive culture results. Additionally,
cultures were negative in 176 cases with 46 broad-range PCR-
positive samplings. We rated 14 of 69 (16%) species found in
broad-range PCR-positive and culture-negative samplings as
clinically irrelevant (Single detection of a “contaminant” bacterial
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TABLE 2 | Overview on the detected species obtained during surgical revisions among 60 patients with confirmed vascular graft infections.
Species in culture-positive,
PCR-positive speciesa
n (%) Species in culture-positive,
PCR-negative speciesb
n (%) Species in culture-negative,
PCR-positive speciesb
n (%)
Candida sp. 10 (45) Candida sp 8 (20) Staphylococcus epidermidis 21 (30)
Staphylococcus epidermidis 5 (23) Enterococcus spp. 6 (15) Streptococcus spp. 9 (13)
Streptococcus spp. 2 (9) Propionibacterium acnes 5 (12) Enterobacter spp. 4 (6)
Enterobacter spp. 1 (5) Staphylococcus epidermidis 5 (12) Corynebacterium spp. 4 (6)
Propionibacterium acnes 1 (5) Enterobacter spp. 2 (5) Klebsiella spp. 4 (6)
Pseudomonas aeruginosa 1 (5) Eikenella corrodens 2 (5) Citrobacter freundii 3 (4)
Streptococcus spp. 1 (5) Escherichia coli 2 (5) Pseudomonas aeruginosa 3 (4)
Mycoplasma hominis 1 (5) Klebsiella spp. 2 (5) Salmonella enterica 3 (4)
Aspergillus fumigatus 1 (3) Proteus mirabilis 2 (3)
Bacteroides fragilis 1 (3) Raoutella spp. 2 (3)
Corynebacterium spp. 1 (3) Bacteriodes xylanisolvens 1 (1)
Finegoldia magna 1 (3) Dialister invisus 1 (1)
Mycobacterium chimaera 1 (3) Escherichia coli 1 (1)
Pseudomonas aeruginosa 1 (3) Escherichia fergusonii 1 (1)
Staphylococcus spp. 1 (3) Fusobacterium nucleatum 1 (1)
Streptococcus spp. 1 (3) Listeria innocua 1 (1)
Mycobacterium intracellulare 1 (1)
Pasteurella multocida 1 (1)
Pluralibacter pyrinus 1 (1)
Propionibacterium acnes 1 (1)
Shigella spp. 1 (1)
Yokenella spp. 1 (1)
Polymicrobial 2 (3)
Total 22 (100) Total 40 (100) Total 69 (100)
aSample origin: vascular prosthesis (5%), deep wound cultures (80%), superficial wound culture (5%), negative pressure wound therapy foams (10%); bSample origin: vascular prosthesis
(12%), deep wound cultures (78%), superficial wound cultures (10%), biopsy (5%); 3Sample origin: vascular prostheses (5%), biopsy (5%), negative pressure wound therapy foams (5%),
deep wound cultures (78%), superficial wound cultures (6%).
pathogen such as S. epidermidis, P. acnes, Corynebacterium spp.).
Low bacterial inoculum and small amounts of bacterial DNA
substantiated our decision. The mismatch of 30% comparing
broad-range PCR and culture is consistent with recent studies
(6, 15).
We found remarkably high rates (176 specimens) of
negative microbiological results among samples, obtained after
preoperative therapeutic administration of antimicrobial agents.
Many patients with VGIs receive antimicrobial treatment prior
to hospital admission thus complicating the microbiological
diagnosis. Broad-range PCR from specimens with (n = 206)
and without antimicrobial pretreatment (n = 20) contributed to
a microbiological diagnosis in 19 and 50% of culture-negative
VGI, respectively (Supplementary Table 2). The rate of culture-
negative findings was higher than in previously reported studies
(6). Nevertheless, our findings extend previous reports on VGIs
(6) and from studies on orthopedic infections (24, 25) that
combined diagnostics with PCR and wound culture was more
sensitive than deep wound cultures alone.
The high prevalence of Gram-positive cocci (S. epidermidis,
Streptococcus spp., Enterococcus spp. and Corynebacterium spp.)
has been reported before (3, 4, 21, 26). In contrast to our
expectations (6, 26, 27), we found only limited numbers of
S. aureus, whereas Gram-negative pathogens, anaerobes and
fungi were predominantly found in intracavitary abdominal or
extracavitary graft infections consistent with previous reports (1).
This study has several strengths. To our knowledge, it
represents the most comprehensive prospective assessment of
the use of molecular microbiological methods in VGIs to date.
Additionally, molecular and culture methods were obtained in
parallel in order to preclude false-positive results by contaminant
pathogens (23). Moreover, a multi-disciplinary team of ID
specialists, cardiovascular surgeons, microbiologists, and nuclear
medicine specialists adjudicated each VGIs diagnosis. Some
limitations should also be noted.Molecular approaches surveying
bacterial diversity provide a less biased depiction of skin
microbiota than culture-based assays, but molecular approaches
currently on use are unable to distinguish between 16S rRNA
genes that are derived from living versus dead bacteria.
Furthermore sequencing of 16S r RNA genes does not
provide information regarding the gene content of plasmids.
However, DNA extraction of complex microbial communities
is highly influenced by the quality of the recovered DNA.
Molecular techniques are cost-intensive, bear the risk of sample
contamination and are allegedly less effective in case of
polymicrobial infections. Ideally, samples from suspected VGIs
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FIGURE 4 | Bacterial count (A) and Leucocyte count (B) among broad-range PCR-positive/culture-negative and broad-range PCR-negative/culture-positive
specimens. RNA, ribonucleic acid; PCR, polymerase chain reaction.
would have been investigated as well. However, as re-operative
surgery is performed only in case of confirmed infection this was
not feasible.
In conclusion, in about one third of cases with culture-
negative specimens, the broad-range PCR allowed a
microbiological diagnosis. Culture-positive, PCR-negative
isolates were present among tissue samples with either low
bacterial load, fungi or in 28% of cases contaminants were
detected. With regard to enhanced microbiological diagnosis
of VGI, we suggest to apply deep wound cultures as well
as broad-range PCR in order to increase microbiological
diagnosis especially in patients already undergoing antimicrobial
treatment.
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